OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
Bing Yang, Liqing Lu, Dongmei Zhou, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18
Bing Yang, Liqing Lu, Dongmei Zhou, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18
Showing 18 citing articles:
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 26
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 26
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 13
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 13
Hepatokines and Their Role in Cardiohepatic Interactions in Heart Failure
Wael A Shouman, Sarah Najmeddine, Lilas Sinno, et al.
European Journal of Pharmacology (2025), pp. 177356-177356
Closed Access | Times Cited: 1
Wael A Shouman, Sarah Najmeddine, Lilas Sinno, et al.
European Journal of Pharmacology (2025), pp. 177356-177356
Closed Access | Times Cited: 1
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 6
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 6
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis
Jeong-Su Park, Jin Sun Lee, Feng Wang, et al.
Experimental & Molecular Medicine (2025)
Open Access
Jeong-Su Park, Jin Sun Lee, Feng Wang, et al.
Experimental & Molecular Medicine (2025)
Open Access
Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD
Moeka Nakashima, Naoko Suga, Yuka Ikeda, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 1, pp. 11-11
Open Access | Times Cited: 3
Moeka Nakashima, Naoko Suga, Yuka Ikeda, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 1, pp. 11-11
Open Access | Times Cited: 3
Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe
Maria Chondrogianni, Ioannis Kyrou, Θεόδωρος Ανδρουτσάκος, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Maria Chondrogianni, Ioannis Kyrou, Θεόδωρος Ανδρουτσάκος, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy
Liu Yang, Jie Yang, YU Feng-hua, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Liu Yang, Jie Yang, YU Feng-hua, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Gliclazide Reduces Colitis-Associated Colorectal Cancer Formation by Deceasing Colonic Inflammation and Regulating AMPK-NF-κB Signaling Pathway
Shuai Cheng Li, Yanan Wang, Dongdong Zhang, et al.
Digestive Diseases and Sciences (2023) Vol. 69, Iss. 2, pp. 453-462
Open Access | Times Cited: 5
Shuai Cheng Li, Yanan Wang, Dongdong Zhang, et al.
Digestive Diseases and Sciences (2023) Vol. 69, Iss. 2, pp. 453-462
Open Access | Times Cited: 5
Liver-based inter-organ communication: A disease perspective
Xin-Yan Luo, Si-Qi Ying, Yuan Cao, et al.
Life Sciences (2024) Vol. 351, pp. 122824-122824
Closed Access | Times Cited: 1
Xin-Yan Luo, Si-Qi Ying, Yuan Cao, et al.
Life Sciences (2024) Vol. 351, pp. 122824-122824
Closed Access | Times Cited: 1
Signaling pathways that activate hepatic stellate cells during liver fibrosis
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Involvement of the vagus nerve and hepatic gene expression in serum adiponectin concentrations in mice
Naoto Hashimoto, Ryuji Nagata, Kyu‐Ho Han, et al.
Journal of Physiology and Biochemistry (2023) Vol. 80, Iss. 1, pp. 99-112
Closed Access | Times Cited: 3
Naoto Hashimoto, Ryuji Nagata, Kyu‐Ho Han, et al.
Journal of Physiology and Biochemistry (2023) Vol. 80, Iss. 1, pp. 99-112
Closed Access | Times Cited: 3
Lower muscular strength is associated with greater liver fat content and higher serum liver enzymes—“The Sedentary's Liver” The Study of Health in Pomerania
C. A. Mayer, Till Ittermann, Sabine Schipf, et al.
European Journal of Sport Science (2024) Vol. 24, Iss. 6, pp. 824-833
Open Access
C. A. Mayer, Till Ittermann, Sabine Schipf, et al.
European Journal of Sport Science (2024) Vol. 24, Iss. 6, pp. 824-833
Open Access
Inhibition of the RXRA-PPARα-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model
Weiwei Zhang, Linghuan Wang, Yujia Wang, et al.
Science China Life Sciences (2024)
Closed Access
Weiwei Zhang, Linghuan Wang, Yujia Wang, et al.
Science China Life Sciences (2024)
Closed Access
Noncoding RNAs and N6-Methyladenosine Involved in the Development of MAFLD
Moeka Nakashima, Naoko Suga, Yuka Ikeda, et al.
(2023)
Open Access | Times Cited: 1
Moeka Nakashima, Naoko Suga, Yuka Ikeda, et al.
(2023)
Open Access | Times Cited: 1
Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis
Yibing Wang, Hanhan Yu, Zhipeng Cen, et al.
Metabolism Open (2023) Vol. 21, pp. 100267-100267
Open Access | Times Cited: 1
Yibing Wang, Hanhan Yu, Zhipeng Cen, et al.
Metabolism Open (2023) Vol. 21, pp. 100267-100267
Open Access | Times Cited: 1
An Update on the Etiopathogenesis of NAFLD including Organokines for Early Diagnosis and Improvement of Management and Preventing Early HCC Development: A Narrative Review
Kulvinder Kochar Kaur, Gautam Allahbadia, Mandeep Singh
Liver Research - Open Journal (2023) Vol. 4, Iss. 1, pp. 18-41
Open Access | Times Cited: 1
Kulvinder Kochar Kaur, Gautam Allahbadia, Mandeep Singh
Liver Research - Open Journal (2023) Vol. 4, Iss. 1, pp. 18-41
Open Access | Times Cited: 1
U-Shaped relationship of insulin-like growth factor I and incidence of nonalcoholic fatty liver in patients with pituitary neuroendocrine tumors: a cohort study
Yan Hu, Yuan Chen, Muila Abdulnaimu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Yan Hu, Yuan Chen, Muila Abdulnaimu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
